Home Latest Articles
Latest Articles
  • Ruifeng WANG, Yanbin LIN, Xiaoye SU, Guowei HU
    Chinese Journal of Pharmaceuticals. 2025, 56(12): 1535-1544.

    To further improve the applicability of production process and safety of production operations, this study established a chromatography method without ethanol or phenol for the preparation of pneumococcal polysaccharides. With the process control capability(including the recovery ability of the target substance and the impurity removal effect) and crucial quality attributes of the product as the main evaluation indicators, this study confirmed the crucial process parameter as follows: ultrafiltration cassettes with a molecular weight cut-off of 100 000, ultrafiltration dialysis multiples≥20,hexadecyl trimethyl ammonium bromide mass fraction of 1.0%(3.0% for pneumococcal polysaccharide type 23F),chromatography buffer pH value of 6.7 - 7.1. In compliance with the commercial production scale, the chromatography method was used to isolate and purify pneumococcal polysaccharides. The quality of the pneumococcal polysaccharides prepared by the chromatography method is in line with the standards of ChP 2020 Edition. And the polysaccharides exhibited good stability over 60 months. It indicated that the established process were stable and reliable, providing a technical support for the commercial-scale production of pneumococcal polysaccharide.

  • Jiangwei LYU, Yijia ZHANG, Xilong LIANG, Wenjun ZHANG, Youpeng QU
    Chinese Journal of Pharmaceuticals. 2025, 56(12): 1545-1552.

    To improve the dissolution and bioavailability of poorly soluble drugs, a novel drug delivery system based on periodic mesoporous organosilicas(PMOs) was proposed. The PMOs carriers were synthesized via a hydrothermal method using 1,2-bis(triethoxysilyl)ethane(BTEE) as the bridged organosilica precursor. The poorly soluble drug fenofibrate(1) was loaded onto the carriers to obtain the drug delivery system, 1/PMOs. The the carrier structure, in vitro dissolution and in vivo bioavailability of the drug were investigated. The results showed that the PMOs exhibited a uniform mesoporous structure with a pore size of 3.65 nm, and the pore walls were composed of an organic-inorganic hybrid amorphous framework containing ethane groups. Compared with the bulk drug 1, 1/PMOs significantly increased the in vitro dissolution rate of drug, achieving over 90% dissolution within 5 min. In vivo pharmacokinetic studies in rats demonstrated that the relative bioavailability of 1/PMOs was increased to 800% of that of the 1 suspension. This enhancement could be attributed to the high specific surface area of the carrier, which allowed the drug to be highly dispersed and physically adsorbed within the ordered mesopores. Due to the limitations of the pore channels, the drug remained in a water-soluble amorphous state, thereby accelerating its dissolution in the gastrointestinal tract and improving its in vivo absorption. This strategy effectively solves the low oral bioavailability of 1.

  • Yudi HU, Fan ZHANG
    Chinese Journal of Pharmaceuticals. 2025, 56(12): 1553-1559.

    The overfill volume of monoclonal antibody injections significantly affects drug quality, production costs, and clinical safety, making it a critical consideration during drug development, production, and regulatory review.This study used Osemitamab monoclonal antibody injection(labeled as 7.5 mL) as the object. The properties of the drug solution were determined by viscosity and density measurements, and hold-up volume tests were conducted by simulating clinical operations(n=90). The upper control limit(UCL) for the variability of hold-up volume of penicillin bottles and syringes was determined to be 0.39 mL using statistical process control chart analysis. Based on the accuracy of the filling production line(with a variability of 2%), the excess filling volume was calculated to be 0.54 mL, the target filling volume was 8.04 mL, and the filling volume control range was 7.89 - 8.19 mL. Compared with the traditional method(target filling volume of 8.22 mL), the optimized method can save 2.2% of the drug solution and significantly reduce production costs,which provided practical guidance and references for the formulation of biological product filling strategies.

  • Haiwei HUANG, Song YUAN, Yixuan WANG, Liju YU, Hua CHEN
    Chinese Journal of Pharmaceuticals. 2025, 56(12): 1560-1565.

    A HPLC-charged aerosol detector(CAD) method based on hydrophilic interaction chromatography(HILIC) mode was established for the determination of related substances and content of voglibose in bulk drug. An Agilent InfinityLab Poroshell 120 HILIC-Z column(3.0 mm×150 mm, 2.7 μm) was used, with 200 mmol/L ammonium formate solution(pH 3.0 adjusted with formic acid) and acetonitrile (250∶750) as the mobile phase. The flow rate was 0.5 mL/min, the column temperature was 50 ℃. The temperature of the CAD was 50 ℃, the data acquisition frequency was 2 Hz, and the filtration constant was 3.6 s. The methodological research results showed that the separation between the main component and various impurities was good, and there was a good linear relationship of the main component and various impurities in the corresponding mass concentration ranges. The average recoveries of three known impurities (n=9) were 103.0%, 99.0%, and 95.6%, with RSD of 4.1%, 5.6%, and 4.2%, respectively. The average recovery of main component(n=9) was 100.0%, with RSD of 1.1%. The detection limits for voglibose and its impuritiesⅠ, Ⅱ, Ⅲ were 1.3, 2.6, 3.3, and 1.5 ng, respectively. This method is easy to operate and has high specificity, which can provide a reference for the quality control research of strongly polar compounds without ultraviolet absorption.

  • Xiaowei CHEN, Zehua HAO, Honghua LU, Jifa LIU, Jiao TNAG, Guizhou HAO
    Chinese Journal of Pharmaceuticals. 2025, 56(12): 1566-1569.

    A UPLC-MS/MS method was established for the determination of nitrosamine drug substance-related impurities(NDSRIs), 2-(1-nitrosopiperidin-4-yl)-1H-benzo[d]imidazole(2) and 1-(2-ethoxyethyl)-2-(1-nitrosopiperidin-4-yl)-1H-benzo[d]imidazole(3) in bilastine(1). A Hypersil Gold column(2.1 mm×100 mm, 3 μm) was used with 0.1% formic acid solution as mobile phase A and acetonitrile as mobile phase B under linear gradient elution conditions. Mass spectrometry was performed using an electrospray ionization(ESI) source in positive ion mode with selective reaction monitoring(SRM) for detection. The results showed that good linear relationships were obtained for 2 and 3 in the range of 0.2 - 4.0 ng/mL. The limits of quantification were 0.020 6 and 0.021 0 ng/mL, and the limits of detection were 0.006 2 and 0.006 3 ng/mL, respectively. The average recoveries(n=9) were 100.98% and 101.25%, with the RSDs of 0.95% and 1.25%, respectively. This study can provide a reference for the NDSRIs control of 1.

  • Xia WANG, Tingting XU, Guanghua ZHANG, Ze XUAN, Ying YAO
    Chinese Journal of Pharmaceuticals. 2025, 56(12): 1570-1575.

    The applicability of culture media after 4-hour exposure for dynamic monitoring of settling microbes in cleanrooms was validated in this study. Referring to the technical requirements of AppendixⅠ of “Good Manufacturing Practice (2010 Revision)”(GMP) and Chinese Pharmacopoeia 2020 Edition(ChP 2020) Part Ⅳ, General Chapter 9205,six groups of 40 prefilled plates(with 90 mm diameter) containing tryptic soy agar(TSA) were separately exposed in a biosafety cabinet for 30 min and 4 h, respectively. After exposure, the plates were weighed to calculate water loss rate, and media applicability was validated using the spread plate method in accordance with the ChP 2020 General Chapter 1105.The results showed that under the conditions of temperature of 17 - 26 ℃, relative humidity of 12% - 63%, descending airflow velocity of 0.32 - 0.33 m/s, and inflow airflow velocity of 0.54 - 0.56 m/s, the maximum water loss rate of the medium was 27.84%, and the recovery ratios of all tested bacteria ranged from 0.5 to 2.0. This study confirmed that the 4-hour exposure of culture medium for dynamic monitoring of settled plates in cleanrooms met the requirements of General Chapter 1105 of the ChP 2020 .

  • Zhijun ZHOU, Feifei WANG, Li LI, Ying ZHAO, Yu LIU, Ren HAN
    Chinese Journal of Pharmaceuticals. 2025, 56(12): 1576-1582.

    To develop the cleaning procedure for in situ cleaning(CIP) of solution preparation unit in biopharmaceutical production, this study optimized the process in two phases. In the first phase, the water storage step for water for injection cleaning in the original procedure was eliminated. After cleaning 5 tanks and pipelines, full inspections were performed on the collected samples. Subsequently, microbial limit tests were conducted daily for 3 consecutive days, and this entire process was repeated for 3 rounds. The minimum value of the post-cleaning hold time across the 3 rounds was defined as the post-cleaning hold time. In the second phase, the optimized procedure was divided into two CIP processes: post-production CIP(pre-cleaning with purified water + alkaline cleaning) and the pre-production CIP(cleaning with purified water + water for injection). Representative tanks and the most difficult-to-clean components were selected.Sampling and testing were carried out after adhering to the preset dirt hold time, alkaline hold time, and post-cleaning hold time. This phase was repeated for 2 rounds. Finally, the key parameters of the cleaning process(including the CIP procedure,pre-cleaning hold time, alkaline hold time, and post-cleaning hold time) were determined for use in the concurrent cleaning validation during production.

  • Shang CAO, Wenyan XU, Yi FAN
    Chinese Journal of Pharmaceuticals. 2025, 56(12): 1583-1590.
  • Jiajia HAN, Fangzhe YUAN, Yang JIAO, Jingchun SUN, Shuzhen CHU
    Chinese Journal of Pharmaceuticals. 2025, 56(12): 1591-1597.
  • Junyong LUO, Qiaoying LI, Wenzhi YANG, Shanshan LI, Wenjing CUI
    Chinese Journal of Pharmaceuticals. 2025, 56(12): 1598-1601.
News